Where does ONL Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ONL Therapeutics's 10 recorded funding rounds.

Premier Alternatives

ONL Therapeutics

Ann Arbor, MI · Founded 2011 · Privately Held (backing)

Operator of a biopharmaceutical company intended to protect and improve patients' vision with various retinal diseases and conditions. ONL Therapeutics is based in Ann Arbor, MI and was founded in 2011. It has raised $133 million across 10 recorded rounds; the latest was a $60 million later-stage round in Sep 2024.

Last price · $/share

—

Implied valuation

—

Total raised

$132.5M

Last round

Later Stage VC

Sep 2024

Cap table — not yet on record

ONL Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of ONL Therapeutics with a free account

·The complete investor list: 26 names
·Watch ONL Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about ONL Therapeutics

Where does ONL Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ONL Therapeutics's 10 recorded funding rounds.